For more information on the benefits and risks of ketamine, check out Andrew Huberman's latest podcast to learn more.

Treatment-resistant depression is a severe and debilitating condition that affects millions of people worldwide. Those with depression are roughly three times more likely than the general population to commit violent crimes. Traditional antidepressant medications and therapies may not always provide relief for these individuals, leading researchers and healthcare providers to explore alternative treatments. One such treatment that has gained attention is ketamine.

Many patients are finding relief from treatment-resistant depression, PTSD and other chronic illnesses by utilizing ketamine to improve their symptoms.

With many patients hearing about the success that Ketamine (through both IV treatments or assisted psychotherapy) is having on Treatment Resistant Depression, suicidal ideations and PTSD, more of them are interested in knowing if their health insurance covers Ketamine treatments. Find out the answers to all your questions surrounding medication assistance, insurance reimbursement, and Ketamine treatments.

Brain injuries are a serious problem in the United States. Each year, an estimated 2.5 million people suffer a traumatic brain injury (TBI) and about 5.3 million people have post-traumatic stress disorder (PTSD). These mental health conditions can be life-altering, and often require long-term treatment. And until recently, there was a big unknown on how to effectively treat both PTSD and TBI.

Ketamine infusion therapy is becoming a more common treatment for chronic pain, as it is seen as a more comfortable alternative to spinal stimulators. Ketamine has been shown to be effective in treating conditions such as complex regional pain syndrome (CRPS) and neuropathic pain, with few side effects.

If you are considering ketamine infusion therapy for your chronic pain condition, here is what you need to know.

When it comes to treating severe depression, there are a few different options available.

*Disclaimer: As of September 29, 2023, NeuroMend no longer offers Spravato treatments. We apologize for any inconvenience and encourage you to consult with our team or your healthcare provider for alternative options.

The FDA approved form of Ketamine (Spravato or Esketamine) hitting the market has sparked many consumers' curiosity. What is it? Is it covered by my insurance? Keep reading for answers to a few questions you may have about Spravato™.

*Disclaimer: As of September 29, 2023, NeuroMend no longer offers Spravato treatments. We apologize for any inconvenience and encourage you to consult with our team or your healthcare provider for alternative options.

We have been working hard at getting back to our customers during this harsh COVID-19 season. And we are excited to be opening our clinic back up with a brand new treatment offering!

Keep reading to discover the latest news around Neuromend's REMS Spravato certification!

Since setting goals for the new year, you've looked forward to taking steps to implement change and make this year the best yet. Now, midway through the summer, those goals have fallen by the wayside and you're no further on the progression track of life than you were six months to a year ago. This realization can be overwhelming.

How did you fall so far off course when you were so determined such a short period ago?

Disclaimer: As of September 29, 2023, NeuroMend no longer offers Spravato treatments. We apologize for any inconvenience and encourage you to consult with our team or your healthcare provider for alternative options.

Effective immediately, the U.S. Food and Drug Administration has approved the use of Spravato (esketamine) nasal spray for the treatment of treatment-resistant depression, more commonly known as TRD.